Title:
トリアゾロベンゾジアゼピン及びバゾプレシンアンタゴニストとしてのそれらの使用
Document Type and Number:
Japanese Patent JP2008510789
Kind Code:
A
Abstract:
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein R represents H, C1-6 alkyl, SO2R1, SO2NR1R2, or COR1; R1 and R2 independently represent C1-6 alkyl; and Ring A represents a phenyl ring or a pyridinyl ring; may be useful in the treatment of anxiety, cardiovascular disease (including angina, atherosclerosis, hypertension, heart failure, edema, hypernatremia), dysmenorrhoea (primary and secondary), endometriosis, emesis (including motion sickness), intrauterine growth retardation, inflammation (including rheumatoid arthritis), mittlesmerchz, preclampsia, premature ejaculation, premature (preterm) labor and Raynaud's disease.
More Like This:
Inventors:
Johnson, Patrick Stephen
Application Number:
JP2007529032A
Publication Date:
April 10, 2008
Filing Date:
August 12, 2005
Export Citation:
Assignee:
Pfizer Inc.
International Classes:
C07D487/04; A61K31/5517; A61P1/08; A61P7/10; A61P9/00; A61P9/04; A61P9/10; A61P9/12; A61P15/00; A61P15/06; A61P25/00; A61P29/00
Attorney, Agent or Firm:
Yoshinobu Murofushi
Previous Patent: プロテインキナーゼ阻害薬としてのピラゾール置換アミノへテロアリール...
Next Patent: プロテインキナーゼ阻害薬としてのエナンチオピュアなアミノヘテロアリ...
Next Patent: プロテインキナーゼ阻害薬としてのエナンチオピュアなアミノヘテロアリ...